Skip to navigation Skip to content

Severe aplastic anaemia Program in Pharmaceutical Benefits Scheme (PBS) 012-24041212



This document outlines details of PBS-subsidised eltrombopag for patients with severe aplastic anaemia.

For information on how to process a PBS Authority, see Processing Complex Authority Required Listings.

On this page:

Severe aplastic anaemia first-line treatment quick reference

Severe aplastic anaemia second-line treatment quick reference

Severe aplastic anaemia first-line treatment quick reference

Table 1

Restrictions

Authority level and section

PA assessment

Processing system

Prescriber type

Prescriber self-service

First-line

treatment

PB362 form

Written

Electronic

S100:
eltrombopag

No

OPA

Not specified

Yes

Grandfather

first-line

treatment

PB363 form

Written

Electronic

S100:
eltrombopag

No

OPA

Not specified

Yes

Severe aplastic anaemia second-line treatment quick reference

Table 2

Restrictions

Authority level and section

PA assessment

Processing system

Prescriber type

Prescriber self-service

Initial

second-line

treatment

PB362 form

Written

Electronic

S100:
eltrombopag

No

OPA

Not specified

Yes

Continuing

second-line

treatment

Telephone

Electronic

S100:
eltrombopag

No

OPA

Not specified

Yes